Steven Cohen's VIR Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.95 M shares of Vir Biotechnology, Inc. (VIR) worth $17.49 M, representing 0.02% of the portfolio. First purchased in 2021-Q3, this medium-term investment has been held for 16 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in VIR, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2021, adding 2.03 M shares. Largest reduction occurred in Q1 2022, reducing 2.06 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Vir Biotechnology (VIR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Vir Biotechnology (VIR) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +1.76 M | Add 897.47% | 1.95 M | $8.96 |
| Q4 2025 | +195,718 | New Buy | 195,718 | $6.03 |
| Q1 2025 | -848,454 | Sold Out | 0 | $0.00 |
| Q4 2024 | +843,239 | Add 16169.49% | 848,454 | $7.34 |
| Q3 2024 | -12,385 | Reduce 70.37% | 5,215 | $7.49 |
| Q2 2024 | -14,900 | Reduce 45.85% | 17,600 | $8.90 |
| Q1 2024 | +24,500 | Add 306.25% | 32,500 | $10.13 |
| Q4 2023 | +4,900 | Add 158.06% | 8,000 | $10.06 |
| Q3 2023 | -508,500 | Reduce 99.39% | 3,100 | $9.37 |
| Q2 2023 | -1.17 M | Reduce 69.60% | 511,600 | $24.53 |
| Q1 2023 | +1.68 M | New Buy | 1.68 M | $23.27 |
| Q4 2022 | -54,496 | Sold Out | 0 | $0.00 |
| Q3 2022 | +54,496 | New Buy | 54,496 | $19.29 |
| Q1 2022 | -2.06 M | Sold Out | 0 | $0.00 |
| Q4 2021 | +2.03 M | Add 9370.51% | 2.06 M | $41.87 |
| Q3 2021 | +21,700 | New Buy | 21,700 | $43.50 |
Steven Cohen's Vir Biotechnology Investment FAQs
Steven Cohen first purchased Vir Biotechnology, Inc. (VIR) in Q3 2021, acquiring 21,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Vir Biotechnology, Inc. (VIR) for 16 quarters since Q3 2021.
Steven Cohen's largest addition to Vir Biotechnology, Inc. (VIR) was in Q4 2021, adding 2,055,100 shares worth $86.05 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,952,234 shares of Vir Biotechnology, Inc. (VIR), valued at approximately $17.49 M.
As of the Q1 2026 filing, Vir Biotechnology, Inc. (VIR) represents approximately 0.02% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Vir Biotechnology, Inc. (VIR) was 2,055,100 shares, as reported at the end of Q4 2021.